STAT+: Access to heart drugs improves in middle-income countries, but still lags compared to wealthy nations

Middle-income countries have gained greater access to a variety of needed cardiovascular medicines, but remain unable to close the gap with wealthy nations, according to a recent analysis of sales data in dozens of countries.

From 2008 to 2018, the compound annual growth rate for all cardiovascular medicines was nearly 10% in middle-income countries compared with almost 1% in high-income nations. As a result, use of those drugs was six times higher in wealthy countries than lower-income nations in 2018, compared to a 15-fold difference a decade earlier.

Continue to STAT+ to read the full story…

Source link

Comments are closed, but trackbacks and pingbacks are open.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy